Essential role of nitric oxide in sepsis-induced impairment of endothelium-derived hyperpolarizing factor-mediated relaxation in rat pulmonary artery

European Journal of Pharmacology

Volumn 630, Issue 1-3, 2010, Pages 84-91

  Subramani, Jaganathan ^a   Leo, Marie Dennis Marcus ^a   Kathirvel, Kandaswamy ^a   Arunadevi, Rathinam ^a   Singh, Thakur Uttam ^a   Prakash, Vellanki Ravi ^a   Mishra, Santosh Kumar ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

1400W; EDHF; Endothelial dysfunction; INOS inhibition; Pulmonary artery; Sepsis

Indexed keywords

ACETYLCHOLINE; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; GENE EXPRESSION; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PULMONARY ARTERY; RAT; SEPSIS; VASODILATATION;

ANIMALS; BIOLOGICAL FACTORS; ENDOTHELIUM, VASCULAR; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; MALE; NITRIC OXIDE; PULMONARY ARTERY; RATS; RATS, WISTAR; SEPSIS;

EID: 77649179281     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.12.026     Document Type: Article

References (37)

1. Aschner J.L., Smith T.K., Kovacs N., Pinheiro J.M.B., Fuloria M. Mechanisms of bradykinin-mediated dilation in newborn piglet pulmonary conducting and resistance vessels. Am. J. Physiol. Lung Cell Mol. Physiol. 2002, 283:L373-L382.
2. Bauersachs J., Popp R., Hecker M., Sauer E., Fleming I., Busse R. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation 1996, 94:3341-3347.
3. Boer C., Groeneveld J.A.B., Scheffer G.J., De Lange J.J., Westerhof N., Sipkema P. Induced nitric oxide impairs relaxation but not contraction in endotoxin-exposed rat pulmonary arteries. J. Surg. Res. 2005, 127:197-202.
4. Chen G., Suzuki H., Weston A.H. Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. Br. J. Pharmacol. 1988, 95:1165-1174.
5. Cohen R.A., Plane F., Najibi S., Huk I., Malinski T., Garland C.J. Nitric oxide is the mediator of both endothelium-dependent relaxation and hyperpolarization of the rabbit carotid artery. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:4193-4198.
6. Cui X., Wu R., Zhou M., Simas H.H., Wang P. Differential expression of cytochrome P450 isoforms in the lungs of septic animals. Crit. Care Med. 2004, 32:1186-1191.
7. EI-Awady M.S.H., Smirnov S.V., Watson M.L. Desensitization of the soluble guanylyl cyclase/cGMP pathway by lipopolysaccharide in rat isolated pulmonary artery but not aorta. Br. J. Pharmacol. 2008, 155:1164-1173.
8. Fullerton D.A., McIntyre R.C., Hahn A.R., Agrafojo J., Koike K., Meng X., Banerjee A., Harken A.H. Dysfunction of cGMP-mediated pulmonary vasorelaxation in endotoxin-induced acute lung injury. Am. J. Physiol. 1995, 268:L1029-L1035.
9. Fuloria M., Smith T.K., Aschner J.L. Role of 5, 6-epoxyeicosatrienoic acid in the regulation of newborn piglet pulmonary vascular tone. Am. J. Physiol. Lung Cell Mol. Physiol. 2002, 283:L383-L389.
10. Ca channels. FASEB J. 2004, 18:1382-1391.
11. Griffiths M.J.D., Messent M., Macallister R.J., Evans T.W. Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br. J. Pharmacol. 1993, 110:963-968.
12. Hasunuma K., Yamaguchi T., Rodman D.M., O'Brien R.F., McMurtry I.F. Effects of inhibitors of EDRF and EDHF on vasoreactivity of perfused rat lungs. Am. J. Physiol. 1991, 260:L97-L104.
13. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 2003, 348:138-150.
14. Hu J., Cotgreave I.A. Differential regulation of gap junctions by proinflammatory mediators in vitro. J. Clin. Invest. 1997, 99:2312-2316.
15. Karamsetty M.R., Nakashima J.M., Ou L.C., Klinger J.R., Hill N.S. EDHF contributes to strain-related differences in pulmonary arterial relaxation in rats. Am. J. Physiol. Lung Cell Mol. Physiol. 2001, 280:L458-L464.
16. Kessler P., Popp R., Busse R., Schini-Kerth V.B. Proinflammatory mediators chronically downregulate the formation of the endothelium-derived hyperpolarizing factor in arteries via a nitric oxide/cyclic GMP-dependent mechanism. Circulation 1999, 99:1878-1884.
17. Kilpatrick E.V., Cocks T.M. Evidence for differential roles of nitric oxide (NO) and hyperpolarization in endothelium-dependent relaxation of pig isolated coronary artery. Br. J. Pharmacol. 1994, 112:557-565.
18. Leo M.D.M., Siddegowda Y.K.B., Kumar D., Tandan S.K., Sastry K.V.H., Prakash V.R., Mishra S.K. Role of nitric oxide and carbon monoxide in N-Nitro-l-arginine methyl ester-resistant acetylcholine-induced relaxation in chicken carotid artery. Eur. J. Pharmacol. 2008, 596:111-117.
19. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) method. Methods 2001, 25:402-408.
20. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
21. Luksha L., Agewall S., Kublickiene K. Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease. Atherosclerosis 2009, 202:330-344.
22. McIntyre R.C., Banerjee A., Agrafojo J., Fullerton D.A. Pulmonary hypertension in acute lung injury is due to impaired vasodilation with intact vascular contractility. J. Surg. Res. 1995, 8:765-770.
23. Mishra S.K., Abbot S.E., Choudhury Z., Cheng M., Khatab N., Maycock N.J.R., Zavery A., Aaronson P.I. Endothelium-dependent relaxation of rat aorta and main pulmonary artery by the phytoestrogens genistein and daidzein. Cardiovas. Res. 2000, 46:539-546.
24. Moloney E.D., Evans T.W. Pathophysiology and pharmacological treatment of pulmonary hypertension in acute respiratory distress syndrome. Eur. Respir. J. 2003, 21:720-727.
25. Morio Y., Carter E.P., Oka M., McMurtry I.F. EDHF-mediated vasodilation involves different mechanisms in normotensive and hypertensive rat lungs. Am. J. Physiol. Heart Circ. Physiol. 2003, 284:H1762-H1770.
26. Okamoto I., Abe M., Shibata K., Shimizu N., Sakata N., Katsuragi T., Tanaka K. Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture. Am. J. Respir. Crit. Care Med. 2000, 162:716-722.
27. Sagach V., Bondarenko A., Bazilyuk O., Kotsuruba A. Endothelial dysfunction: possible mechanisms and ways of correction. Exp. Clin. Cardiol. 2006, 1:107-110.
28. Scott J.A., Metha S., Duggan M., Bihari A., McCormack D.G. Functional inhibition of constitutive nitric oxide synthase in a rat model of sepsis. Am. J. Respir. Crit. Care Med. 2002, 165:1426-1432.
29. Scumpia P.O., Sarcia P.J., Demarco V.G., Stevens B.R., Skimming J.W. Hypothermia attenuates iNOS, CAT-1, CAT-2, and nitric oxide expression in lungs of endotoxemic rats. Am. J. Physiol. Lung Cell Mol. Physiol. 2002, 283:L1231-L1238.
30. Sheridan B.C., McIntyre R.C., Meldrum D.R., Meng X., Fullerton D.A. Endotoxin stuns cGMP-mediated pulmonary vasorelaxation. Shock 1997, 8:207-212.
31. Tojo A., Kimoto M., Wilcox C.S. Renal expression of constitutive NOS and DDAH: separate effects of salt intake and angiotensin. Kidney Int. 2000, 58:2075-2083.
32. Tracey A., Bunton D., Irvine J., MacDonald A., Shaw A.M. Relaxation to bradykinin in bovine pulmonary supernumerary arteries can be mediated by both a nitric oxide-dependent and -independent mechanism. Br. J. Pharmacol. 2002, 137:538-544.
33. Tsai B.M., Wang M., Pitcher J.M., Kher A., Brown J.W., Meldrum D.R. Endothelium-dependent pulmonary artery vasorelaxation is dysfunctional in males but not females after acute lung injury. Surgery 2005, 138:78-84.
34. v channel gene expression in rat distal pulmonary artery. Am. J. Physiol. Lung Cell Mol. Physiol. 2005, 288:L1049-L1058.
35. Wichterman K.A., Baue A.E., Chaudry I.H. Sepsis and septic shock-a review of laboratory models and a proposal. J. Surg. Res. 1980, 29:189-201.
36. Zhang X., Recchia F.A., Bernstein R., Xu X., Nasjletti A., Hintze T.H. Kinin-mediated coronary nitric oxide production contributes to the therapeutic action of angiotensin-converting enzyme and neutral endopeptidase inhibitors and amlodipine in the treatment in heart failure. J. Pharmacol. Exp. Ther. 1999, 288:742-751.
37. Zhang R.Z., Yang Q., Yim A.P.C., Huang Y., He G.W. Role of NO and EDHF-mediated endothelial function in the porcine pulmonary circulation: comparison between pulmonary artery and vein. Vascul. Pharmacol. 2006, 44:183-191.